Skip to content

The effect of remifentanil on endotracheal intubation

Comparison of different doses of remifentanil on tracheal intubation in the absence of muscle relaxants

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201110216803N2
Enrollment
162
Registered
2011-10-27
Start date
2006-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In the absence of muscle relaxants to facilitate intubation. Failed or difficult intubation

Interventions

Intervention 1: intervention 1: Remifentanil 2 µg/kg. Intervention 2: intervention 2 : Remifentanil 3 µg/kg.
Treatment - Drugs
intervention 1: Remifentanil 2 µg/kg
intervention 2 : Remifentanil 3 µg/kg

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Informed written consent; ASA class ?-??; Age between 18 and 50 years; Elective surgery; Mallampati class ?-??. Exclusion criteria: History of difficult intubation; Pulmonary diseases; Recent respiratory tract infection; History of previous surgery on the larynx; Smoking; Gastroesophageal reflux; Hiatal hernia; Substance abuse; Pregnancy; Obesity; Renal diseases (baseline serum creatinine > 2mg/dl); Hepatic diseases (liver function tests > 1.5 times of the normal upper limit).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Tracheal intubation. Timepoint: 90 seconds after induction of anesthesia. Method of measurement: on the movement and position of vocal cord, airway reaction and limb movement as excellent, good and poor will be assessed.

Secondary

MeasureTime frame
Systolic pressure. Timepoint: Immediately and 5 min after laryngoscopy and tracheal intubation. Method of measurement: manometer.;Diastolic pressure. Timepoint: Immediately and 5 min after laryngoscopy and tracheal intubation. Method of measurement: manometer.;Heart rate. Timepoint: Immediately and 5 min after laryngoscopy and tracheal intubation. Method of measurement: manitoring.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026